Global Equine Healthcare Market 2026-2030

Description

The global equine healthcare market is forecasted to grow by USD 702232.0 thousand during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global equine healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising expenditure on advanced veterinary care, technological innovation in diagnostic equipment, prevalence of chronic equine diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	6.7%
CAGR	7.2%
Incremental Value	$702232.0 thousand

Technavio's global equine healthcare market is segmented as below:

By Product

Pharmaceuticals
Vaccines
Others

By Distribution Channel

Offline
Online

By Indication

Musculoskeletal disorders
Parasitic infections
Equine herpes virus
Equine viral arteritis
Others

Geography

North America
- US
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- The Netherlands
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the technological advancements in diagnostic imaging as one of the prime reasons driving the global equine healthcare market growth during the next few years. Also, rising investments in equestrian sports and expansion of veterinary telehealth services will lead to sizable demand in the market.

The report on the global equine healthcare market covers the following areas:

Global equine healthcare market sizing
Global equine healthcare market forecast
Global equine healthcare market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global equine healthcare market vendors that include Audevard Laboratories, Bimeda Holdings Ltd., Boehringer Ingelheim GmbH, CAVALOR NA, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Equine Care Group, Esaote SpA, Hallmarq Veterinary Imaging Ltd., IDEXX Laboratories Inc., Merck Animal Health, Multi Radiance Medical, Neogen Corp., Norbrook Laboratories Ltd., Ourofino SA, TRM Ireland, Vetoquinol SA, Virbac Group, Zoetis Inc.. Also, the global equine healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75362

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Equine Healthcare Market 2020 - 2024
- Historic Market Size - Data Table on Global Equine Healthcare Market 2020 - 2024 ($ thousand)
5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ thousand)
5.3 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ thousand)
5.4 Indication segment analysis 2020 - 2024
- Historic Market Size - Indication Segment 2020 - 2024 ($ thousand)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

6.1 Impact of AI on Global Equine Healthcare Market
6.2 Impact of geopolitical conflicts on Global Equine Healthcare Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Product

8.1 Market segments
8.2 Comparison by Product
8.3 Pharmaceuticals - Market size and forecast 2025-2030
8.4 Vaccines - Market size and forecast 2025-2030
8.5 Others - Market size and forecast 2025-2030
8.6 Market opportunity by Product
- Market opportunity by Product ($ thousand)

9 Market Segmentation by Distribution Channel

9.1 Market segments
9.2 Comparison by Distribution Channel
9.3 Offline - Market size and forecast 2025-2030
9.4 Online - Market size and forecast 2025-2030
9.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ thousand)

10 Market Segmentation by Indication

10.1 Market segments
10.2 Comparison by Indication
10.3 Musculoskeletal disorders - Market size and forecast 2025-2030
10.4 Parasitic infections - Market size and forecast 2025-2030
10.5 Equine herpes virus - Market size and forecast 2025-2030
10.6 Equine viral arteritis - Market size and forecast 2025-2030
10.7 Others - Market size and forecast 2025-2030
10.8 Market opportunity by Indication
- Market opportunity by Indication ($ thousand)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 UK - Market size and forecast 2025-2030
- 12.4.2 Germany - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Rising expenditure on advanced veterinary care
- Technological innovation in diagnostic equipment
- Prevalence of chronic equine diseases
13.2 Market challenges
- Persistent of skilled veterinary professionals
- Prohibitive treatment costs and economic pressures
- Complex regulatory hurdles for drug approvals
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Technological advancements in diagnostic imaging
- Rising investments in equestrian sports
- Expansion of veterinary telehealth services

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Bimeda Holdings Ltd.
- Bimeda Holdings Ltd. - Overview
- Bimeda Holdings Ltd. - Product / Service
- Bimeda Holdings Ltd. - Key offerings
- SWOT
15.5 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
15.6 Dechra Pharmaceuticals Plc
- Dechra Pharmaceuticals Plc - Overview
- Dechra Pharmaceuticals Plc - Product / Service
- Dechra Pharmaceuticals Plc - Key offerings
- SWOT
15.7 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
- SWOT
15.8 Equine Care Group
- Equine Care Group - Overview
- Equine Care Group - Product / Service
- Equine Care Group - Key offerings
- SWOT
15.9 Esaote SpA
- Esaote SpA - Overview
- Esaote SpA - Product / Service
- Esaote SpA - Key offerings
- SWOT
15.10 Hallmarq Veterinary Imaging Ltd.
- Hallmarq Veterinary Imaging Ltd. - Overview
- Hallmarq Veterinary Imaging Ltd. - Product / Service
- Hallmarq Veterinary Imaging Ltd. - Key offerings
- SWOT
15.11 IDEXX Laboratories Inc.
- IDEXX Laboratories Inc. - Overview
- IDEXX Laboratories Inc. - Business segments
- IDEXX Laboratories Inc. - Key offerings
- IDEXX Laboratories Inc. - Segment focus
- SWOT
15.12 Merck Animal Health
- Merck Animal Health - Overview
- Merck Animal Health - Product / Service
- Merck Animal Health - Key offerings
- SWOT
15.13 Neogen Corp.
- Neogen Corp. - Overview
- Neogen Corp. - Business segments
- Neogen Corp. - Key offerings
- Neogen Corp. - Segment focus
- SWOT
15.14 Norbrook Laboratories Ltd.
- Norbrook Laboratories Ltd. - Overview
- Norbrook Laboratories Ltd. - Product / Service
- Norbrook Laboratories Ltd. - Key offerings
- SWOT
15.15 Ourofino SA
- Ourofino SA - Overview
- Ourofino SA - Product / Service
- Ourofino SA - Key offerings
- SWOT
15.16 Vetoquinol SA
- Vetoquinol SA - Overview
- Vetoquinol SA - Business segments
- Vetoquinol SA - Key offerings
- Vetoquinol SA - Segment focus
- SWOT
15.17 Virbac Group
- Virbac Group - Overview
- Virbac Group - Business segments
- Virbac Group - Key offerings
- Virbac Group - Segment focus
- SWOT
15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations